Spatially restricted iron-metabolism-associated stress programs prime invasive mesenchymal glioblastoma states in human tissue-context models
Authors:
- Christophe PetryCPChristophe Petry
- Ambra-Stella BoeckeABAmbra-Stella Boecke
- Aso Omer MohammedAMAso Omer Mohammed
- Vatsal D JariwalaVJVatsal D Jariwala
- Mohammad Al ShhabMSMohammad Al Shhab
- Oliver BuchholzOBOliver Buchholz
- Ioannis VasilikosIVIoannis Vasilikos
- Julia M NakagawaJNJulia M Nakagawa
- Andreas VlachosAVAndreas Vlachos
- Jürgen GrauvogelJGJürgen Grauvogel
- Mukesch J ShahMSMukesch J Shah
- 8 October 2026
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
Abstract
Background: Glioblastoma (GBM) recurrence is driven by invasive tumor cells that infiltrate surrounding brain tissue and evade surgical and therapeutic eradication. While dysregulated iron handling is a well-recognized feature of malignant cancers, its contribution to invasive GBM cell states in the physiological context of human cortical tissue remains poorly defined. Methods: We performed multiregional single-nucleus RNA sequencing of human GBM specimens encompassing tumor core, tumor periphery, and infiltrated cortex to map iron-associated transcriptional programs validated by spatial transcriptomics. Correlative analyses were combined with functional validation using patient-derived GBM cell lines and human organotypic cortical slice cultures exposed to noncytotoxic iron supplementation to model iron-rich tumor microenvironments. Results: Malignant cells from the tumor core exhibited coordinated upregulation of iron uptake and storage pathways alongside invasion-associated gene programs. At single-cell resolution, iron metabolism and invasion signatures were correlated, defining a core-enriched malignant subpopulation with mesenchymal-like transcriptional identity, stress-adaptive features, and angiogenic signaling that aggregate in specific spatial niches. Functionally, iron exposure altered migration in a cell-state-dependent manner and increased tumor growth and invasion in human cortical slice cultures. Increased VIM, MMP9, and HIF1A expression was consistent with activation of mesenchymal-like and stress-response programs, although mechanistic dependence was not tested. Conclusion: Iron-handling and invasion-associated programs co-occur in a core-enriched mesenchymal-like GBM state. In patient-derived cell and human cortical slice models, noncytotoxic particulate and soluble iron altered migration in a cell-state-dependent manner and increased tissue invasion. These findings support iron availability as a component of the microenvironment associated with invasive GBM phenotypes, while its necessity and underlying mechanism remain to be established.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (1010 0665 01)
- Deutsche Forschungsgemeinschaft Ma (10605/1-1)
This publication has 43 references indexed in Scilit:
- Ferroptosis and EMT: key targets for combating cancer progression and therapy resistanceCellular and Molecular Life Sciences, 2023
- Technical report: surgical preparation of human brain tissue for clinical and basic researchActa Neurochirurgica, 2023
- Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysisJournal of Neuro-Oncology, 2020
- An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCell, 2019
- Preferential Iron Trafficking Characterizes Glioblastoma Stem-like CellsCancer Cell, 2015
- Heme oxygenase-1 and anti-inflammatory M2 macrophagesArchives of Biochemistry and Biophysics, 2014
- Uptake and Metabolism of Iron Oxide Nanoparticles in Brain CellsNeurochemical Research, 2014
- Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastomaJournal of Neuro-Oncology, 2012
- Iron quantification of microbleeds in postmortem brainMagnetic Resonance in Medicine, 2010
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenBreast Cancer Research and Treatment, 2009